Bong Y Koh

CIK 1615979 · last filed 2025-04-11

Bong Y Koh is a corporate insider who has filed 13 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing shows the insider bought $1.6M of KALV on Apr 11, 2025. Across all open-market trades the lifetime net is +$38.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $152.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$152.34M

Companies

5

Total Filings

13

Lifetime Open-Market Net

$38.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KALV 10%+ Owner 5,303,985 $27.00 $143.21M $19.15M 4 2025-04-11
Tricida, Inc. (TCDA) Delisted 10%+ Owner 7,607,951 $0.11 $821.7K $14.57M 2 2022-09-01
ALT 10%+ Owner 3,500,000 $2.61 $9.13M $0 1 2021-03-01
Bellerophon Therapeutics, Inc. (BLPH) Delisted 10%+ Owner 7,251,163 $0.01 $87.0K $2.52M 1 2018-09-17
AveXis, Inc. (AVXS) Delisted Director 0 $2.00M 5 2018-05-15

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-04-11 KALV Buy (P) +175,000 $1.65M EDGAR
2024-02-22 KALV Buy (P) $0 EDGAR
2024-02-08 KALV Buy (P) +602,336 $8.80M EDGAR
2024-01-24 KALV Buy (P) +693,903 $8.69M EDGAR
2022-09-01 Tricida, Inc. (TCDA) Delisted Buy (P) +500,000 $6.10M EDGAR
2022-07-06 Tricida, Inc. (TCDA) Delisted Buy (P) +882,000 $8.47M EDGAR
2021-03-01 ALT Other (J) −8,000,000 $0 EDGAR
2018-09-17 Bellerophon Therapeutics, Inc. (BLPH) Delisted Buy (P) +2,100,000 $2.52M EDGAR
2018-05-15 AveXis, Inc. (AVXS) Delisted Disp (D) −1,036,763 $0 EDGAR
2018-03-30 AveXis, Inc. (AVXS) Delisted Grant (A) +1,106 $0 EDGAR
Showing 110 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.